Dennis R Voelker

US Patent:

8367643, Feb 5, 2013

Filed:

Mar 28, 2008

Appl. No.:

12/057967

Inventors:

Dennis R. Voelker - Greenwood Village CO, US

Assignee:

National Jewish Health - Denver CO

International Classification:

A61K 35/00
A61K 39/395

US Classification:

514120

Abstract:

The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.

US Patent:

20130217654, Aug 22, 2013

Filed:

Jan 2, 2013

Appl. No.:

13/732929

Inventors:

National Jewish Health - , US
Dennis R. Voelker - Greenwood Village CO, US

Assignee:

NATIONAL JEWISH HEALTH - Denver CO

International Classification:

A61K 31/683

US Classification:

514121

Abstract:

The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.

US Patent:

20220273681, Sep 1, 2022

Filed:

Feb 10, 2022

Appl. No.:

17/669107

Inventors:

- Denver CO, US
Dennis R. VOELKER - Littleton CO, US

International Classification:

A61K 31/683
A61P 31/14
A61K 9/00

Abstract:

The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.

US Patent:

20200009165, Jan 9, 2020

Filed:

Feb 27, 2018

Appl. No.:

16/488865

Inventors:

- Denver CO, US
Dennis R. VOELKER - LIttleton CO, US

Assignee:

National Jewish Health - Denver CO

International Classification:

A61K 31/683
A61P 31/14
A61K 9/00

Abstract:

The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.

US Patent:

20150150891, Jun 4, 2015

Filed:

Jun 27, 2014

Appl. No.:

14/318303

Inventors:

- Denver CO, US
Dennis R. Voelker - Greenwood Village CO, US

International Classification:

A61K 31/683
A61K 9/00

Abstract:

The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.